Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 26.10 is 65% above its 5-year average of 15.84, around the middle of its 5-year range (9.97–42.52).
As of the fiscal period ended Tuesday, June 30, 2026. 31.63% above its 12-month average of 19.83.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 26.10.
CURRENT RATIO
26.10
CURRENT RATIO AVG TTM
19.83
CURRENT RATIO AVG 3Y
19.81
CURRENT RATIO AVG 5Y
15.84
CURRENT RATIO AVG 10Y
15.37
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+31.63%
CURRENT VS 3Y AVG
+31.78%
CURRENT VS 5Y AVG
+64.81%
CURRENT VS 10Y AVG
+69.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 657 covered companies
CURRENT VS SECTOR MEDIAN
+667.63%
vs the sector median at left
Dianthus Therapeutics, Inc.
Market Cap
$4.81B
Current Ratio
26.10
TTM Avg
19.83
3Y Avg
19.81
5Y Avg
15.84
Market Cap
$4.86B
Current Ratio
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
Market Cap
$4.90B
Current Ratio
2.86
TTM Avg
2.88
3Y Avg
3.29
5Y Avg
4.98
Market Cap
$4.69B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.66B
Current Ratio
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.46
Market Cap
$5.06B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.81B | 26.10 | 19.83 | 19.81 | 15.84 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.86B | 38.51 | 25.63 | 37.00 | 29.64 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | 2.86 | 2.88 | 3.29 | 4.98 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | 6.95 | 6.77 | 6.23 | 10.87 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.66B | 1.38 | 1.51 | 1.37 | 1.46 |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 1.47 | 1.61 | 1.69 | 1.64 |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 11.69 | 9.86 | 7.15 | 7.15 |
| Erasca, Inc. (ERAS)vs › | $5.02B | 8.29 | 9.94 | 10.32 | 11.01 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 4.20 | 4.30 | 4.12 | 3.47 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 4.79 | 3.12 | 4.00 | 4.41 |
Current Ratio
26.10
Quick Ratio
26.10
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 26.10 |
| 2026-03-31 | 29.25 |
| 2025-12-31 | 13.32 |
| 2025-09-30 | 17.35 |
| 2025-06-30 | 13.12 |
| 2025-03-31 | 15.99 |
| 2024-12-31 | 15.22 |
| 2024-09-30 | 18.30 |
| 2024-06-30 | 36.46 |
| 2024-03-31 | 42.52 |
| 2023-12-31 | 18.42 |
| 2023-09-30 | 14.64 |
| 2023-06-30 | 19.49 |
| 2023-03-31 | 13.95 |
| 2022-12-31 | 9.97 |
| 2022-09-30 | 10.22 |
| 2022-06-30 | 12.62 |
| 2022-03-31 | 11.37 |
| 2021-12-31 | 16.63 |
| 2021-09-30 | 19.36 |
| 2021-06-30 | 18.96 |
| 2021-03-31 | 14.67 |
| 2020-12-31 | 13.26 |
| 2020-09-30 | 16.65 |
| 2020-06-30 | 17.35 |
| 2020-03-31 | 10.48 |
| 2019-12-31 | 10.62 |
| 2019-09-30 | 17.16 |
| 2019-06-30 | 18.41 |
| 2019-03-31 | 17.06 |
| 2018-12-31 | 13.95 |
| 2018-09-30 | 13.65 |
| 2018-06-30 | 23.13 |
| 2018-03-31 | 7.76 |
| 2017-12-31 | 12.68 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
